Selected research
Industry Research
GMP Lentivirus Production Service Industry Research Report 2026
Market perspective
The global GMP Lentivirus Production Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the GMP Lentivirus Production Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the GMP Lentivirus Production Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the GMP Lentivirus Production Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of GMP Lentivirus Production Service include AGC Biologics, Biocompare, BPS Bioscience, Charles River Laboratories, Creative Biogene, Hillgene Biopharma, OXB, ProBio CDMO and ProBioGen AG, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global GMP Lentivirus Production Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to GMP Lentivirus Production Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
GMP Lentivirus Production Service Market by Company
AGC Biologics
Biocompare
BPS Bioscience
Charles River Laboratories
Creative Biogene
Hillgene Biopharma
OXB
ProBio CDMO
ProBioGen AG
Revvity
SK pharmteco
Thermo Fisher Scientific
VectorBuilder
VIVEbiotech
GMP Lentivirus Production Service Segment by Type
R&D and Preclinical Service
Early Clinical (Phase I/II) Service
Late Clinical and Commercial (Phase III/Launch) Service
GMP Lentivirus Production Service Segment by Application
CAR-T Therapy
Vaccine Development
Gene Editing
Others
GMP Lentivirus Production Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global GMP Lentivirus Production Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of GMP Lentivirus Production Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of GMP Lentivirus Production Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of GMP Lentivirus Production Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- R&D and Preclinical Service
- Early Clinical (Phase I/II) Service
- Late Clinical and Commercial (Phase III/Launch) Service
Applications
- CAR-T Therapy
- Vaccine Development
- Gene Editing
- Others
Companies covered
- AGC Biologics
- Biocompare
- BPS Bioscience
- Charles River Laboratories
- Creative Biogene
- Hillgene Biopharma
- OXB
- ProBio CDMO
- ProBioGen AG
- Revvity
- SK pharmteco
- Thermo Fisher Scientific
- VectorBuilder
- VIVEbiotech
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 GMP Lentivirus Production Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 R&D and Preclinical Service
- 2.2.3 Early Clinical (Phase I/II) Service
- 2.2.4 Late Clinical and Commercial (Phase III/Launch) Service
- 2.3 GMP Lentivirus Production Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 CAR-T Therapy
- 2.3.3 Vaccine Development
- 2.3.4 Gene Editing
- 2.3.5 Others
- 2.4 Assumptions and Limitations
3 GMP Lentivirus Production Service Breakdown Data by Type
- 3.1 Global GMP Lentivirus Production Service Historic Market Size by Type (2021-2026)
- 3.2 Global GMP Lentivirus Production Service Forecasted Market Size by Type (2027-2032)
4 GMP Lentivirus Production Service Breakdown Data by Application
- 4.1 Global GMP Lentivirus Production Service Historic Market Size by Application (2021-2026)
- 4.2 Global GMP Lentivirus Production Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global GMP Lentivirus Production Service Market Perspective (2021-2032)
- 5.2 Global GMP Lentivirus Production Service Growth Trends by Region
- 5.2.1 Global GMP Lentivirus Production Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 GMP Lentivirus Production Service Historic Market Size by Region (2021-2026)
- 5.2.3 GMP Lentivirus Production Service Forecasted Market Size by Region (2027-2032)
- 5.3 GMP Lentivirus Production Service Market Dynamics
- 5.3.1 GMP Lentivirus Production Service Industry Trends
- 5.3.2 GMP Lentivirus Production Service Market Drivers
- 5.3.3 GMP Lentivirus Production Service Market Challenges
- 5.3.4 GMP Lentivirus Production Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top GMP Lentivirus Production Service Players by Revenue
- 6.1.1 Global Top GMP Lentivirus Production Service Players by Revenue (2021-2026)
- 6.1.2 Global GMP Lentivirus Production Service Revenue Market Share by Players (2021-2026)
- 6.2 Global GMP Lentivirus Production Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of GMP Lentivirus Production Service Head Office and Area Served
- 6.4 Global GMP Lentivirus Production Service Players, Product Type & Application
- 6.5 Global GMP Lentivirus Production Service Manufacturers Established Date
- 6.6 Global GMP Lentivirus Production Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America GMP Lentivirus Production Service Market Size (2021-2032)
- 7.2 North America GMP Lentivirus Production Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America GMP Lentivirus Production Service Market Size by Country (2021-2026)
- 7.4 North America GMP Lentivirus Production Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe GMP Lentivirus Production Service Market Size (2021-2032)
- 8.2 Europe GMP Lentivirus Production Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe GMP Lentivirus Production Service Market Size by Country (2021-2026)
- 8.4 Europe GMP Lentivirus Production Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific GMP Lentivirus Production Service Market Size (2021-2032)
- 9.2 Asia-Pacific GMP Lentivirus Production Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific GMP Lentivirus Production Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific GMP Lentivirus Production Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America GMP Lentivirus Production Service Market Size (2021-2032)
- 10.2 South America GMP Lentivirus Production Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America GMP Lentivirus Production Service Market Size by Country (2021-2026)
- 10.4 South America GMP Lentivirus Production Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa GMP Lentivirus Production Service Market Size (2021-2032)
- 11.2 Middle East & Africa GMP Lentivirus Production Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa GMP Lentivirus Production Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa GMP Lentivirus Production Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 AGC Biologics
- 12.1.1 AGC Biologics Company Information
- 12.1.2 AGC Biologics Business Overview
- 12.1.3 AGC Biologics Revenue in GMP Lentivirus Production Service Business (2021-2026)
- 12.1.4 AGC Biologics GMP Lentivirus Production Service Product Portfolio
- 12.1.5 AGC Biologics Recent Developments
- 12.2 Biocompare
- 12.2.1 Biocompare Company Information
- 12.2.2 Biocompare Business Overview
- 12.2.3 Biocompare Revenue in GMP Lentivirus Production Service Business (2021-2026)
- 12.2.4 Biocompare GMP Lentivirus Production Service Product Portfolio
- 12.2.5 Biocompare Recent Developments
- 12.3 BPS Bioscience
- 12.3.1 BPS Bioscience Company Information
- 12.3.2 BPS Bioscience Business Overview
- 12.3.3 BPS Bioscience Revenue in GMP Lentivirus Production Service Business (2021-2026)
- 12.3.4 BPS Bioscience GMP Lentivirus Production Service Product Portfolio
- 12.3.5 BPS Bioscience Recent Developments
- 12.4 Charles River Laboratories
- 12.4.1 Charles River Laboratories Company Information
- 12.4.2 Charles River Laboratories Business Overview
- 12.4.3 Charles River Laboratories Revenue in GMP Lentivirus Production Service Business (2021-2026)
- 12.4.4 Charles River Laboratories GMP Lentivirus Production Service Product Portfolio
- 12.4.5 Charles River Laboratories Recent Developments
- 12.5 Creative Biogene
- 12.5.1 Creative Biogene Company Information
- 12.5.2 Creative Biogene Business Overview
- 12.5.3 Creative Biogene Revenue in GMP Lentivirus Production Service Business (2021-2026)
- 12.5.4 Creative Biogene GMP Lentivirus Production Service Product Portfolio
- 12.5.5 Creative Biogene Recent Developments
- 12.6 Hillgene Biopharma
- 12.6.1 Hillgene Biopharma Company Information
- 12.6.2 Hillgene Biopharma Business Overview
- 12.6.3 Hillgene Biopharma Revenue in GMP Lentivirus Production Service Business (2021-2026)
- 12.6.4 Hillgene Biopharma GMP Lentivirus Production Service Product Portfolio
- 12.6.5 Hillgene Biopharma Recent Developments
- 12.7 OXB
- 12.7.1 OXB Company Information
- 12.7.2 OXB Business Overview
- 12.7.3 OXB Revenue in GMP Lentivirus Production Service Business (2021-2026)
- 12.7.4 OXB GMP Lentivirus Production Service Product Portfolio
- 12.7.5 OXB Recent Developments
- 12.8 ProBio CDMO
- 12.8.1 ProBio CDMO Company Information
- 12.8.2 ProBio CDMO Business Overview
- 12.8.3 ProBio CDMO Revenue in GMP Lentivirus Production Service Business (2021-2026)
- 12.8.4 ProBio CDMO GMP Lentivirus Production Service Product Portfolio
- 12.8.5 ProBio CDMO Recent Developments
- 12.9 ProBioGen AG
- 12.9.1 ProBioGen AG Company Information
- 12.9.2 ProBioGen AG Business Overview
- 12.9.3 ProBioGen AG Revenue in GMP Lentivirus Production Service Business (2021-2026)
- 12.9.4 ProBioGen AG GMP Lentivirus Production Service Product Portfolio
- 12.9.5 ProBioGen AG Recent Developments
- 12.10 Revvity
- 12.10.1 Revvity Company Information
- 12.10.2 Revvity Business Overview
- 12.10.3 Revvity Revenue in GMP Lentivirus Production Service Business (2021-2026)
- 12.10.4 Revvity GMP Lentivirus Production Service Product Portfolio
- 12.10.5 Revvity Recent Developments
- 12.11 SK pharmteco
- 12.11.1 SK pharmteco Company Information
- 12.11.2 SK pharmteco Business Overview
- 12.11.3 SK pharmteco Revenue in GMP Lentivirus Production Service Business (2021-2026)
- 12.11.4 SK pharmteco GMP Lentivirus Production Service Product Portfolio
- 12.11.5 SK pharmteco Recent Developments
- 12.12 Thermo Fisher Scientific
- 12.12.1 Thermo Fisher Scientific Company Information
- 12.12.2 Thermo Fisher Scientific Business Overview
- 12.12.3 Thermo Fisher Scientific Revenue in GMP Lentivirus Production Service Business (2021-2026)
- 12.12.4 Thermo Fisher Scientific GMP Lentivirus Production Service Product Portfolio
- 12.12.5 Thermo Fisher Scientific Recent Developments
- 12.13 VectorBuilder
- 12.13.1 VectorBuilder Company Information
- 12.13.2 VectorBuilder Business Overview
- 12.13.3 VectorBuilder Revenue in GMP Lentivirus Production Service Business (2021-2026)
- 12.13.4 VectorBuilder GMP Lentivirus Production Service Product Portfolio
- 12.13.5 VectorBuilder Recent Developments
- 12.14 VIVEbiotech
- 12.14.1 VIVEbiotech Company Information
- 12.14.2 VIVEbiotech Business Overview
- 12.14.3 VIVEbiotech Revenue in GMP Lentivirus Production Service Business (2021-2026)
- 12.14.4 VIVEbiotech GMP Lentivirus Production Service Product Portfolio
- 12.14.5 VIVEbiotech Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst